ArticleAACE endocrinology and diabetes
Decompensated Hypothyroidism in a Patient With Cirrhosis: A Rare Presentation of Severe Hypothyroidism With Hypertension.
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: Decompensated hypothyroidism (DH) is a rare endocrine emergency with a high mortality rate, particularly challenging to distinguish from hepatic encephalopathy (HE) in patients with cirrhosis due to overlapping symptoms. Case Report: We present a case of a 79-year-old woman with advanced cirrhosis and a history of multiple HE-related admissions, who exhibited altered mental status, hypothermia, bradycardia, and unusually high blood pressure. Laboratory findings revealed a severely elevated thyroid-stimulating hormone level (335.10 µUI/mL; reference range, 0.40-4.50 µUI/mL) and low free thyroxine level (0.2 ng/dL; reference range, 0.8-1.8 ng/dL), confirming DH. Adrenal insufficiency was ruled out. Intravenous levothyroxine was administered with a dose adjustment over 4 days, leading to significant clinical improvement by hospital day 1 and recovery to baseline by day 4. Discussion: This case highlights the complexity of diagnosing and managing DH in the context of cirrhosis. Notably, the pronounced hypertension observed may reflect compensatory systemic vasoconstriction in response to a low cardiac output state. Conclusion: The complexity and severity of concomitant DH and HE underscore the necessity of prompt recognition and tailored treatment to prevent further complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.